Search

Your search keyword '"Mosina, Liudmila"' showing total 27 results
Start Over Author "Mosina, Liudmila"
27 results on '"Mosina, Liudmila"'

2. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

Author

Mallah, Narmeen, primary, Pardo-Seco, Jacobo, additional, Rivero-Calle, Irene, additional, Zhu-Huang, Ouhao, additional, Fernández Prada, María, additional, Reynen-de Kat, Catharina, additional, Benes, Oleg, additional, Mosina, Liudmila, additional, Sankar-Datta, Siddhartha, additional, Aleksinskaya, Olga, additional, Díaz, David, additional, Allahverdiyeva, Vusala, additional, Grechukha, Yevgenii, additional, Jobava, Tamara, additional, Savchyna, Mariia, additional, Kortusova, Pavla, additional, Novac, Ioana, additional, and Martinón-Torres, Federico, additional

Published
2024
Full Text
View/download PDF

4. Evaluating the hepatitis B vaccination impact in the Republic of Moldova: a nationwide representative serosurvey of children born in 2013

Author

Brandl, Michael, primary, Ceban, Alexei, additional, Sajin, Octavian, additional, Bucov, Victoria, additional, Cataraga, Alina, additional, Stratulat, Silvia, additional, Furtuna, Nicolae, additional, Gutu, Veaceslav, additional, Gheorghita, Stela, additional, Gassowski, Martyna, additional, Mosina, Liudmila, additional, Mozalevskis, Antons, additional, Dudareva, Sandra, additional, and Datta, Siddhartha Sankar, additional

Published
2023
Full Text
View/download PDF

10. Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization

Author

Markovic-Denic, Ljiljana, primary, Popadic, Dusan, additional, Jovanovic, Tanja, additional, Bonaci-Nikolic, Branka, additional, Samardzic, Janko, additional, Tomic Spiric, Vesna, additional, Rancic, Miljan, additional, Sankar Datta, Siddhartha, additional, Mosina, Liudmila, additional, Jancic, Jasna, additional, Vukomanovic, Goran, additional, Jovanovic, Verica, additional, Vukomanovic, Vladislav, additional, Antic, Darko, additional, Veljkovic, Marko, additional, Saponjic, Vladan, additional, and Jacques-Carroll, Lisa, additional

Published
2022
Full Text
View/download PDF

11. Progress Toward Hepatitis B Control--World Health Organization European Region, 2016-2019

Author

Khetsuriani, Nino, Mosina, Liudmila, Van Damme, Pierre, Mozalevskis, Antons, Datta, Siddhartha, and Tohme, Rania A.

Subjects
Public health -- Health aspects, Hepatitis B -- Health aspects -- Control, Hepatitis B vaccine -- Health aspects, Health
Abstract

In 2019, an estimated 14 million persons in the World Health Organization (WHO) European Region * (EUR) were chronically infected with hepatitis B virus (HBV), and approximately 43,000 of these [...]

Published
2021

12. Impact and effectiveness of monovalent rotavirus vaccine in Tajik children

Author

Nazurdinov, Anvar, primary, Azizov, Zafarjon, additional, Mullojonova, Manija, additional, Sadykova, Umeda, additional, Mosina, Liudmila, additional, Singh, Simarjit, additional, Suleymonova, Sudoba, additional, Tishkova, Farida, additional, Videbaek, Dovile, additional, Cortese, Margaret M., additional, Daniels, Danni S., additional, and Burke, Rachel M., additional

Published
2022
Full Text
View/download PDF

13. Corrigendum to “HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019” [Preventive Medicine 144 (2021) 106399]

Author

Bruni, Laia, Saura-Lázaro, Anna, Montoliu, Alexandra, Brotons, Maria, Alemany, Laia, Diallo, Mamadou Saliou, Afsar, Oya Zeren, LaMontagne, D. Scott, Mosina, Liudmila, Contreras, Marcela, Velandia-González, Martha, Pastore, Roberta, Gacic-Dobo, Marta, and Bloem, Paul

Published
2022
Full Text
View/download PDF

14. Rotavirus Burden among Children in the Newly Independent States of the Former Union of Soviet Socialist Republics: Literature Review and First-Year Results from the Rotavirus Surveillance Network

Author

members of the Rotavirus Surveillance Network, Mirzayeva, Radmila, Cortese, Margaret M., Mosina, Liudmila, Biellik, Robin, Lobanov, Andrei, Chernyshova, Lyudmila, Lashkarashvili, Marina, Turkov, Soibnazar, Iturriza-Gomara, Miren, Gray, Jim, Parashar, Umesh D., Steele, Duncan, and Emiroglu, Nedret

Published
2009
Full Text
View/download PDF

15. Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform

Author

Mosina, Liudmila, primary, Külper-Schiek, Wiebe, additional, Jacques-Carroll, Lisa, additional, Earnshaw, Andrew, additional, Harder, Thomas, additional, Martinón-Torres, Federico, additional, Wilder-Smith, Annelies, additional, Wichmann, Ole, additional, and Datta, Siddhartha Sankar, additional

Published
2021
Full Text
View/download PDF

16. Global vaccinology training: Report from an ADVAC workshop

Author

Duclos, Philippe, Martinez, Lindsay, MacDonald, Noni, Asturias, Edwin, Nohynek, Hanna, Lambert, Paul-Henri, Afaayo, Rachel, Andersson, Lizzelott, Angele, Sandra, Arora, Narendra, Ashfield, Rebecca, Beal, Amanda Shortell, Bose, Anuradha, Comiadiere, Behazine, Costa Clemens, Sue Ann, Cutland, Clare, Dochez, Carine, Finan, Amy, Finn, Adam, Gambillara Fonck, Veronica, Kagina, Benjamin, Kane, Ndeye Coumba Toure, Koeck, Jean-Louis, Kraehenbuhl, Jean-Pierre, Lindstrand, Ann, Lynch, Julia Anne, Macdonald, Noni, Malande, Oliver Ombeva, Meric, Claude, Mosina, Liudmila, Muloiwa, Rudzani, Pansier, Benedicte, Pattyn, Jade, Paul, Stephane, Phalipon, Armelle, Podda, Audino, Rodewald, Lance, Scott, Anthony, Talbot, Keipp, Tikoo, Suresh, Tipping, Jane, van Damme, Pierre, Wang, Likui, Wouters, Ine, University of Geneva [Switzerland], Dalhousie University [Halifax], University of Colorado Anschutz [Aurora], National Institute for Health and Welfare [Helsinki], Université de Genève (UNIGE), all participants of the Global Vaccinology Training Workshop : Rachel AFAAYO, East Africa Centre for Vaccines and Immunization, Uganda, Lizzelott ANDERSSON, Carlos Slim Foundation, with endorsement of the National Autonomous University of Mexico, Mexico, Sandra ANGELE, Fondation Mérieux, France, Narendra ARORA, Child Foundation/INCLEN, India, Rebecca ASHFIELD, University of Oxford/Jenner Institute, UK, Edwin ASTURIAS, University of Colorado, USA, Amanda SHORTELL BEAL, Bill & Melinda Gates Foundation, USA Anuradha BOSE, Christian Medical College, India, Béhazine COMBADIERE, INSERM, France, Sue Ann COSTA CLEMENS, Institute for Global Health-University of Siena, Italy, Clare CUTLAND, University of the Witwatersrand, South Africa, Carine DOCHEZ, University of Antwerp, Belgium, Philippe DUCLOS, University of Geneva, Switzerland, Amy FINAN, Sabin Vaccine Institute, USA, Adam FINN, University of Bristol, UK, Veronica GAMBILLARA FONCK, Limmatech Biologics, Switzerland, Benjamin KAGINA, University of Cape Town, South Africa, Ndeye Coumba Touré KANE, Université de Dakar, Sénégal, Jean-Louis KOECK, Direction Centrale du Service de Santé des Armées, France, Jean-Pierre KRAEHENBUHL, Health Sciences E-training Foundation, Switzerland, Paul-Henri LAMBERT, University of Geneva, Switzerland, Ann LINDSTRAND, World Health Organization, Switzerland, Julia Anne LYNCH, International Vaccine Institute, Korea, Noni MACDONALD, Dalhousie University, Canada, Oliver Ombeva MALANDE, Africa Centre For Vaccines and Immunization, Kenya, Lindsay MARTINEZ, Freelance Consultant, Switzerland, Claude MERIC, Freelance Consultant, Switzerland, Liudmila MOSINA, WHO Regional Office for Europe, Denmark, Rudzani MULOIWA, University of Cape Town, South Africa, Hanna NOHYNEK, National Institute for Health and Welfare, Finland, Bénédicte PANSIER, Fondation Mérieux, France, Jade PATTYN, University of Antwerp, Belgium, Stéphane PAUL, Université Jean Monet, France, Armelle PHALIPON, Institut Pasteur, France, Audino PODDA, GSK Vaccines Institute for Global Health, Italy, Lance RODEWALD, Chinese Center for Disease Control and Prevention, China, Anthony SCOTT, London School of Hygiene and Tropical Medicine, UK, Keipp TALBOT, Vanderbilt University Medical Center, USA, Suresh TIKOO, University of Saskatchewan, Canada, Jane TIPPING, Faculty of Medicine, University of Toronto, Canada, Pierre VAN DAMME, University of Antwerp, Vaccine and Infectious Diseases Institute, Belgium, Likui WANG, University of Chinese Academy of Sciences, China, Ine WOUTERS, University of Antwerp, Belgium., Université de Genève = University of Geneva (UNIGE), and Global Vaccinology Training Works

Subjects
Computer science, Best practice, 030231 tropical medicine, Training (civil), 03 medical and health sciences, 0302 clinical medicine, Adult education, ComputingMilieux_COMPUTERSANDEDUCATION, Humans, 030212 general & internal medicine, Workshop, Constraint (mathematics), Information exchange, Vaccines, General Veterinary, General Immunology and Microbiology, Public Health, Environmental and Occupational Health, Global, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Vaccinology, Engineering management, Infectious Diseases, Molecular Medicine, Education, Medical, Continuing, Human medicine, Advanced vaccinology training, Vaccinology training
Abstract

At a workshop on 7-8 November 2018 the leaders of 26 advanced vaccinology courses met to carry out an extensive review of the existing courses worldwide, in order to identify education gaps and future needs and discuss potential collaboration. The main conclusions of the workshop concerned: opportunities for strengthening and expanding the global coverage of vaccinology training; evaluation of vaccinology courses; updating knowledge after the course; how to facilitate post-course 'cascade' training; developing and sharing best practices; the application of online and innovative approaches in adult education; and how to reduce costs and facilitate wider access to vaccinology training. The importance of collaboration and information exchange through networks of alumni and between courses was stressed. A web platform to provide information about existing courses for potential applicants is needed. Lack of sustainable funding is a constraint for vaccinology training and needs to be addressed. (C) 2019 The Authors. Published by Elsevier Ltd.

Published
2019

17. Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities

Author

Steffen, Christoph A., primary, Henaff, Louise, additional, Durupt, Antoine, additional, Omeiri, Nathalie El, additional, Ndiaye, Sidy, additional, Batmunkh, Nyambat, additional, Liyanage, Jayantha B.L., additional, Hasan, Quamrul, additional, Mosina, Liudmila, additional, Jones, Ian, additional, O'Brien, Katherine, additional, and Hombach, Joachim, additional

Published
2021
Full Text
View/download PDF

20. Rotavirus burden among children in the newly independent states of the former Union of Soviet Socialist Republics: literature review and first-year results from the rotavirus surveillance network

Author

Mirzayeva, Radmila, Cortese, Margaret M., Mosina, Liudmila, Biellik, Robin, Lobanov, Andrei, Chernyshova, Lyudmila, Lashkarashvili, Marina, Turkov, Soibnazar, Iturriza-Gomara, Miren, Gray, Jim, Parashar, Umesh D., Steele, Duncan, and Emiroglu, Nedret

Subjects
Rotaviruses -- Complications and side effects, Rotaviruses -- Demographic aspects, Rotaviruses -- Prognosis, Rotaviruses -- Prevention, Gastroenteritis -- Risk factors, Gastroenteritis -- Demographic aspects, Gastroenteritis -- Prognosis, Viral vaccines -- Usage, Viral vaccines -- Health aspects, Health
Published
2009

21. Progress towards hepatitis B control -- WHO European Region, 2016-2019.

Author

Khetsuriani, Nino, Mosina, Liudmila, Van Damme, Pierre, Mozalevskis, Antons, Datta, Siddhartha, and Tohme, Rania A.

Subjects
*HEPATITIS B prevention, *VIRAL antigens, *IMMUNIZATION, *PREVENTION of communicable diseases, *MEDICAL screening, *HEPATITIS viruses, *MEDICAL protocols, *HEPATITIS B vaccines, *VERTICAL transmission (Communicable diseases)
Abstract

The article reports on the accomplishments in the efforts by the World Health Organization (WHO) to control the proliferation of hepatitis B in the European region (EUR) as of July 2021. Other topics include the number of people who were infected and died due to the hepatitis B virus (HBV) in 2019, and the efforts to prevent mother-to-child transmission (MTCT) of HBV.

Published
2021

22. Progress in the establishment and strengthening of national immunization technical advisory groups: Analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012

Author

Duclos, Philippe, primary, Dumolard, Laure, additional, Abeysinghe, Nihal, additional, Adjagba, Alex, additional, Janusz, Cara Bess, additional, Mihigo, Richard, additional, Mosina, Liudmila, additional, Takashima, Yashohiro, additional, and Öztürk, Murat Hakan, additional

Published
2013
Full Text
View/download PDF

23. Indicators to assess National Immunization Technical Advisory Groups (NITAGs)

Author

Blau, Julia, primary, Sadr-Azodi, Nahad, additional, Clementz, Marine, additional, Abeysinghe, Nihal, additional, Cakmak, Niyazi, additional, Duclos, Philippe, additional, Janusz, Cara, additional, Jauregui, Barbara, additional, Mihigo, Richard, additional, Mosina, Liudmila, additional, Takashima, Yoshihiro, additional, and Senouci, Kamel, additional

Published
2013
Full Text
View/download PDF

24. Monitoring of progress in the establishment and strengthening of national immunization technical advisory groups

Author

Duclos, Philippe, primary, Ortynsky, Stephanie, additional, Abeysinghe, Nihal, additional, Cakmak, Niyazi, additional, Janusz, Cara Bess, additional, Jauregui, Barbara, additional, Mihigo, Richard, additional, Mosina, Liudmila, additional, Sadr-Azodi, Nahad, additional, Takashima, Yashohiro, additional, Dumolard, Laure, additional, and Gacic-Dobo, Marta, additional

Published
2012
Full Text
View/download PDF

27. Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.

Author

Khetsuriani N, Mosina L, Van Damme P, Mozalevskis A, Datta S, and Tohme RA

Subjects
Adolescent, Adult, Aged, Child, Child, Preschool, Europe epidemiology, Female, Hepatitis B Surface Antigens blood, Hepatitis B Vaccines administration & dosage, Humans, Immunization Schedule, Infant, Infant, Newborn, Male, Middle Aged, Post-Exposure Prophylaxis, Pregnancy, Prenatal Diagnosis statistics & numerical data, Seroepidemiologic Studies, World Health Organization, Young Adult, Hepatitis B epidemiology, Hepatitis B prevention & control
Abstract

In 2019, an estimated 14 million persons in the World Health Organization (WHO) European Region* (EUR) were chronically infected with hepatitis B virus (HBV), and approximately 43,000 of these persons died from complications of chronic HBV infection (1). In 2016, the WHO Regional Office for Europe set hepatitis B control program targets for 2020, including 1) ≥90% coverage with 3 doses of hepatitis B vaccine (HepB3), 2) ≥90% coverage with interventions to prevent mother-to-child transmission (MTCT) of HBV, † and 3) ≤0.5% prevalence of HBV surface antigen (HBsAg) § in age groups eligible for vaccination with hepatitis B vaccine (HepB) (2-4). This report describes the progress made toward hepatitis B control in EUR during 2016-2019. By December 2019, 50 (94%) of 53 countries in EUR provided routine vaccination with HepB to all infants or children aged 1-12 years (universal HepB), including 23 (43%) countries that offered hepatitis B birth dose (HepB-BD) to all newborns. In addition, 35 (73%) of the 48 countries with universal infant HepB vaccination reached ≥90% HepB3 coverage annually during 2017-2019, and 19 (83%) of the 23 countries with universal birth dose administration achieved ≥90% timely HepB-BD coverage annually during that period. Antenatal hepatitis B screening coverage was ≥90% in 17 (57%) of 30 countries that selectively provided HepB-BD to infants born to mothers with positive HBsAg test results. In January 2020, Italy and the Netherlands became the first counties in EUR to be validated to have achieved the regional hepatitis B control targets. Countries can accelerate progress toward hepatitis B control by improving coverage with HepB and interventions to prevent MTCT and documenting achievement of the HBsAg seroprevalence target through representative serosurveys or, in low-endemicity countries, antenatal screening., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results